Diabetes and Endocrinology Center

Request Appointment

(813)-821-8011

Refer a Patient

Clinical Trials - Pediatric

Currently Enrolling T1D Studies

TrialNet Logo

Eligibility:

  • For Individuals who are 2-45 years of age with a parent, child, brother, or sister with T1D.
  • For Individuals who are 2-20 years of age with a niece, nephew, aunt, uncle, grandparent, half-sibling or cousin with T1D.

Or

  • Are between the ages of 2 and 45 years and have tested positive for at least one type 1 diabetes related autoantibody outside of TrialNet.
  • Have not been diagnosed with diabetes.

Purpose: This study helps to identify family members of people with T1D who might have antibodies associated with T1D. Relatives of people with T1D have a 3-4 percent chance of testing positive for antibodies. If participants are found to be antibody positive they will be offered follow up screening and further tests to determine their risk for T1D. Depending on the outcome of those tests, participants may qualify for prevention studies offered by TrialNet.

For more information visit TrialNet on the web. 

Coordinators:  Juanita O'Brian, CMA, CCRC; Henry Rodriguez, MD

Contact: usfdiabetesresearchc@usf.edu | Phone Number: (813) 974-9817

TrialNet Logo

Eligibility:

  • Age 12-35
  • Newly diagnosed with T1D in the last 3 months

Coordinator: Bethany Dunn, RN,BSN

Contact: usfdiabetesresearchc@usf.edu l Phone Number (813) 974-4886

Currently Enrolling Osteogenesis Imperfecta (OI) Studies

Eligibility:

  • Ambulatory children and adolescents, age 5 to < 18 years, including ambulatory with assistance as defined in the pediatric OI population
  • Confirmed diagnosis of Osteogenesis Imperfecta types 1, 2, or 4
  • 3 or more fractures within the previous 2 years, or 1 or more nonvertebral fracture(s) within the previous 2 years and at least 1 prevalent vertebral fracture, or 2 or more prevalent vertebral fractures.

Purpose: Study to Evaluate Efficacy and Safety of Romosozumab Compared with Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

Coordinator: Ponja Hemphill, RN

Contact: CRC-health@usf.edu 

TEDDY Study compares characteristics of children diagnosed with type 1 diabetes before and after age 6

New findings from the international The Environmental Determinants of Diabetes in the Young (TEDDY) study add to the growing body of evidence indicating that type 1 diabetes is not a single disease.

Click here to view full article.


USF Awarded Four-Year, $69.9 Million NIH Grant to Continue Type 1 Diabetes Research

The Environmental Determinants of Diabetes in the Young study is led by USF Health’s Jeffrey Krischer, who has built a worldwide epidemiological hub for T1D research at USF. 

Click here to view full article. 


Nature highlights USF Health-led TEDDY study as a diabetes research milestone

Click here to view article.


USF Health Informatics Institute contributes to new NIH study indicating that measuring gene expression changes over time may help predict type 1 diabetes progression in at-risk children, and lead to earlier diagnosis of the autoimmune disease.

Click here to read the full article.  


USF Diabetes Center Focuses on Pathway to Prevention
How Can I Help Find A Way to Prevent Type 1 Diabetes?